Rezo Therapeutics, a biotechnology company pioneering the integrated mapping of disease networks for precision therapeutics, today announced the appointment of Cristiana Guiducci, Ph.D., as chief scientific officer. Dr. Guiducci previously served as senior vice president of immunology and oncology research of Nurix Therapeutics and has nearly 20 years of experience in oncology and immunology drug discovery research.
Nevan Krogan, PhD, and Kevan Shokat, PhD, are the lead UCSF inventors upon which Rezo Therapeutics was founded.